Neogen Corporation (NEOG) Comparison with companies in other sectors?

Neogen Corporation has a share price of 217.04M. You can analyze Neogen Corporation (NEOG) competitors across different market sectors through stock heatmaps.

What are NEOG's NET and operating margins?

Neogen Corporation (NEOG) operating margin is around -0.48, and net profit margin is approximately -0.54 as of the latest reports.

In what way does NEOG's earnings per share (EPS) trend reflect its financial momentum?

Neogen Corporation (NEOG) EPS is -2.23 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Neogen Corporation is -2.34, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Neogen Corporation?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Neogen Corporation like P/E which is -2.34, P/B which is 0.43, and PEG which is 1.28. Compare them with sector averages to evaluate if the stock is priced fairly.

Neogen Corporation

NEOG•NASDAQ

Healthcare

Medical - Diagnostics & Research

$5.22

$0.10(1.95%)

Fundamental Analysis of Neogen Corporation (NEOG)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

$-2.23

P/E Ratio

-2.34

ROE

-0.17%

Net Margin

-0.54%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$1.13B

Shares OutstandingTotal number of shares issued

$217.04M

Book Value/ShareNet worth per share

$12.26

Revenue/ShareAnnual revenue per share

$4.17

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$-2.23

Net MarginNet income as percentage of revenue

-53.56%

Operating MarginOperating income as percentage of revenue

-47.71%

ROEReturn on shareholders' equity

-16.72%

ROAReturn on total assets

-12.02%

ROCEReturn on capital employed

-11.10%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$0.05

Cash/ShareCash and equivalents per share

$0.59

FCF YieldFree cash flow as percentage of market cap

0.99%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for NEOGFinancial Ratios Analysis details for NEOG are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for NEOGSector Benchmarking details for NEOG are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Neogen Corporation Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Neogen Corporation. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Neogen Corporation's unique business strengths and challenges.

Key Financial Metrics for Neogen Corporation

For Neogen Corporation, essential financial indicators include EPS -2.23, PE -2.34, and ROE -0.17. These key ratios reveal insights into Neogen Corporation's profitability, valuation, and operational health. Understanding these metrics enables you to compare Neogen Corporation with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Neogen Corporation

Metrics like Net Margin -53.56% and ROA -12.02% shed light on how well Neogen Corporation is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Neogen Corporation can sustain its operations and continue growing in the future.

Valuation and Market Position of Neogen Corporation

Using ratios such as P/B Ratio 0.43 and PEG Ratio 1.28, investors can assess whether Neogen Corporation is appropriately valued based on its financials and growth potential. These figures, combined with Neogen Corporation's market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Neogen Corporation

Financial health indicators, such as Debt/Equity Ratio 0.34 and Cash Flow $0.05, provide a snapshot of Neogen Corporation's ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Neogen Corporation, is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Neogen Corporation

Investing in Neogen Corporation based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Neogen Corporation focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;